Now that those who follow our Newsletter are up to speed (sign up here, if you haven’t already), we’re excited to announce publicly that after an extensive code audit by Level K, we have transitioned the Matryx platform from the Ropsten Testnet to the Ethereum Mainnet.

The Code Audit

Working with Level K was a great learning experience. They were very professional and able to give security recommendations with varying severities that were communicated and resolved in an effective manner.

They found that the Matryx Platform smart contract code did not contain any critical issues. We worked tirelessly to address, remedy, and close all of the high and medium severity level issues.

If you’re curious about reviewing the audited code, it is located here.

Collaboration Tracking and Crowdsource Science

Matryx’s pillars are First-To-Hash, Collaboration Tracking and Crowdsourcing Science, which we believe will disrupt STEM industries. Proper collaboration tracking allows for all IP contributors to be properly rewarded and the ability to crowdsource any scientific interest allows for trust-less parties to contribute towards a shared goal in a secure manner with appropriate attribution.

The Matryx platform enables scientific enthusiasts, academic researchers, and pharmaceutical professionals the ability to have proof of each innovation along the path to discovery, including who contributed what.

You can create your own Matryx Tournaments to crowdsource scientific innovation secured through smart contract technology on the Ethereum Blockchain.

Real world diagram of a current timestamping method at a pharmaceutical company (Fujitsu Sci. Tech. J., Vol 50, No3, pp. 68–73 July 2014)

Enterprise Use Case Scenario

Until now, pharmaceutical companies have had to spend hundreds of millions of dollars a year on third-party timestamp services to document the discovery process of new potential medicines for FDA auditors and to protect their IP.

By documenting the drug discovery process, a pharmaceutical company can prove that they’ve discovered a new medicine. This means additional costs to the drug discovery process using current methods.

Our decentralized third-party notebook timestamp, ‘First to Hash’, can democratize third party timestamp authorities and reduce that cost.

Pharmaceutical organizations can prove they were the first to invent a new drug and leverage this during patent defense conversations.

‘First to Hash’ creates immutable proof that you began work on a new innovation before any other individual or organization.

This has been years in the making and today you can try it for yourself. We hope that you are able to share with your colleagues (#FirstToHash), contribute to an existing challenge, or even start your own tournament.

You can even create your own Matryx Tournament to crowdsource and crowdfund scientific discoveries secured through smart contract technology on the Ethereum Blockchain.

We believe that Nanome’s VR solutions, coupled with blockchain secure IP tracking, will disrupt the scientific community.

Not interested in First-To-Hash, Collaboration Tracking and the Crowdsourcing of Science? Check out the following links:

Development of a virtual reality platform for effective communication of structural data in drug discovery

Our article co-authored with The Genomics Institute of the Novartis Research Foundation.

From the article: “Which combination of technologies will provide the optimal solution is as yet unknown, but it is clear that the Molecular Graphics field has yet to fully explore the advantages of working collaboratively in a virtual molecular modelling world. Nanome was developed to explore these possibilities with a goal of minimizing the need for technical know-how, and making molecular structure and dynamics more intuitive.”

Exploring the Molecules of Chemical Warfare in Virtual Reality

Our CEO Steve McCloskey interviews UC San Diego professor and Nanome advisor Zoran Radić, an expert on such compounds used Nanome’s VR molecular visualization software to explore the nerve agent — Novichok A-234 in 3D–used in the poisoning in a former Soviet and UK double agent, as well as his daughter, in the United Kingdom.

Scientist See Their Molecules In VR For The First Time

Nanome went to the annual American Crystallography Association meeting — VR software in tow — and showed scientists what the future looks like!

Vuethereum: The Vue library Ethereum deserves

From the article: “Developing blockchain applications for Ethereum (or Dapps) is a roller coaster of emotional ups and downs for developers. The potential decentralization offers is exciting, but the ecosystem is still feeling it’s growing pains as there are still barriers to user adoption and development. As a result, building the frontend for Dapps can be a painful process for developers…until today.